-
Mashup Score: 0Bone & Mineral SIG - 5 month(s) ago
Collaborate and connect with peers on clinical care and research related to bone and mineral metabolism/disorders.
Source: www.endocrine.orgCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 2Bone Socks - 6 month(s) ago
Introducing style and comfort for bone enthusiasts! These socks are an instant conversation starter, featuring a unique bone-inspired pattern that complements any outfit. Made from a premium blend of materials, they wrap your feet in a soft embrace, keeping you cozy, bold, and undeniably cool. Materials: 85% Combed Cotton, 10% Nylon, 5% Spandex
Source: www.endocrine.orgCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 4Bone & Mineral SIG - 6 month(s) ago
Collaborate and connect with peers on clinical care and research related to bone and mineral metabolism/disorders.
Source: www.endocrine.orgCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Member Benefits - 6 month(s) ago
Learn how we foster a dynamic, interdisciplinary endocrinology community, from bench to bedside.
Source: www.endocrine.orgCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 1PFAS Chemicals: EDCs Contaminating Our Water and Food Supply - 6 month(s) ago
Per- and polyfluoroalkyl substances (PFAS) are manmade chemicals used as oil and water repellents and coatings for common products including cookware, carpets, and textiles. These endocrine-disrupting chemicals do not break down when they are released into the environment, and they continue to accumulate over time.
Source: www.endocrine.orgCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Bone Socks - 6 month(s) ago
Introducing style and comfort for bone enthusiasts! These socks are an instant conversation starter, featuring a unique bone-inspired pattern that complements any outfit. Made from a premium blend of materials, they wrap your feet in a soft embrace, keeping you cozy, bold, and undeniably cool. Materials: 85% Combed Cotton, 10% Nylon, 5% Spandex
Source: www.endocrine.orgCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 1
Abstract. Abstract 3922Poster Board III-858Abstract:Patients diagnosed with lymphoma are at high risk of developing osteoporosis. We have shown previously that
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial - 6 month(s) ago
Micro-AbstractIn patients with newly diagnosed lymphoma, low bone mineral density (BMD) is common at diagnosis and worsens with therapy. Our randomized phase III trial demonstrates that 2 doses of zoledronic acid (ZA) and supplementation with calcium and vitamin D effectively prevent further bone loss.
Categories: Hem/Oncs, Latest HeadlinesTweet-
Zoledronic Acid for Prevention of Bone Loss in Lymphoma [12/29/12] @Lymphoma_Doc @mtmdphd et al. CLML https://t.co/iPOYSXEA1M #lymsm #SuppOnc #BoneHealth - Clinical Practice Points: 1) Incr risk low BMD in ND & incr risk on Tx, 2) 2 doses ZA stabilize BMD, 3) Screening
-
-
Mashup Score: 3
Drs Paccou et al. noted that ‘Adult patients with known lymphoma receiving chemotherapy experienced significant [bone mineral density] BMD loss at 1 year’ [1]. Their conclusions were drawn based upon 32 assessable patients with BMD better than -2.5 by T or Z scores. We find these data to be highly interesting as these results are similar to our randomized phase III clinical trial which evaluated the benefit of zoledronic acid (ZA) in the same lymphoma patient population [2]. In our trial, the patients who received ZA had stable BMD during the observation period.
Source: www.annalsofoncology.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Treatment of diffuse large B-cell lymphoma (DLBCL) with R-CHOP(-like) regimens include large cumulative doses of prednisolone. In this retrospective study, we evaluated changes in vertebral bone density (VD) in DLBCL patients by measuring CT-ascertained Hounsfield units (HU) at the L3 level. In tota …
Source: pubmed.ncbi.nlm.nih.govCategories: Hem/Oncs, Latest HeadlinesTweet
Ask our team at #ASBMR2023 booth #520 about our new Bone & Mineral Special Interest Group. Learn how to join your peers in our exclusive online community: https://t.co/MazoADeRS5 @ASBMR #bonehealth https://t.co/Tx5zeC3wMA